• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆石病与非酒精性脂肪性肝病患者的更严重肝损伤相关。

Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.

机构信息

Department of Internal Medicine, Centro Studi Malattie Metaboliche del Fegato, University of Milano, Maggiore Policlinico Hospital, IRCCS Ca' Granda Foundation, Milano, Italy.

出版信息

PLoS One. 2012;7(7):e41183. doi: 10.1371/journal.pone.0041183. Epub 2012 Jul 25.

DOI:10.1371/journal.pone.0041183
PMID:22848440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3405067/
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) and gallstone disease (GD) are both highly prevalent in the general population and associated with obesity and insulin resistance. We aimed to evaluate the prevalence of GD in a cross sectional study of NAFLD patients and to define whether the presence of GD is associated with diabetes and predicts more severe liver disease.

METHODOLOGY/PRINCIPAL FINDINGS: We merged databases of four Liver Units, comprising 524 consecutive biopsy-proven NAFLD (373 males) observed between January 2003 and June 2010. GD was diagnosed in 108 (20%), and 313 cases (60%) were classified by liver biopsy as nonalcoholic steatohepatitis (NASH). The GD subgroup was characterized by a significantly higher prevalence of females, prediabetes/diabetes, abdominal obesity and metabolic syndrome, older age, higher BMI, fasting glucose, HOMA-IR and lower ALT. The prevalence of GD progressively increased with advancing fibrosis and with the severity of necroinflammatory activity (p for trend  = 0.0001 and  = 0.01, respectively), without differences in the severity of steatosis. At multivariate analysis GD was associated with female gender (OR 1.37, 95% CI 1.04-1.8), age (OR 1.027, 95% CI1.003-1.05), fasting glucose (OR 1.21, 95% CI 1.10-1.33) and NASH (OR 1.40,95% CI 1.06-1.89), whereas ALT levels were associated with a lower GD risk (OR 0.98, 95% CI 0.97-0.99). When subjects with cirrhosis were excluded from analysis, the association between GD and fasting glucose, female gender, and NASH was maintained.

CONCLUSION

Patients with NAFLD have a high prevalence of GD, which characterizes subjects with altered glucose regulation and more advanced liver disease.

摘要

背景

非酒精性脂肪性肝病(NAFLD)和胆石病(GD)在普通人群中都非常普遍,与肥胖和胰岛素抵抗有关。我们旨在评估 NAFLD 患者的 GD 患病率,并确定 GD 的存在是否与糖尿病有关,并预测更严重的肝病。

方法/主要发现:我们合并了四个肝脏单位的数据库,包括 2003 年 1 月至 2010 年 6 月期间观察到的 524 例经活检证实的 NAFLD(373 名男性)。诊断出 108 例(20%)GD,313 例(60%)病例根据肝活检分类为非酒精性脂肪性肝炎(NASH)。GD 亚组的女性、前驱糖尿病/糖尿病、腹部肥胖和代谢综合征、年龄较大、BMI 较高、空腹血糖、HOMA-IR 和较低的 ALT 患病率明显更高。随着纤维化和坏死性炎症活动程度的加重,GD 的患病率逐渐增加(趋势检验的 p 值分别为 0.0001 和 0.01),而脂肪变性的严重程度没有差异。多变量分析显示,GD 与女性性别(比值比 1.37,95%置信区间 1.04-1.8)、年龄(比值比 1.027,95%置信区间 1.003-1.05)、空腹血糖(比值比 1.21,95%置信区间 1.10-1.33)和 NASH(比值比 1.40,95%置信区间 1.06-1.89)有关,而 ALT 水平与 GD 风险降低有关(比值比 0.98,95%置信区间 0.97-0.99)。当排除分析中的肝硬化患者时,GD 与空腹血糖、女性性别和 NASH 之间的关联仍然存在。

结论

NAFLD 患者 GD 的患病率很高,这一特征表明患者的葡萄糖调节发生改变,且肝病更为严重。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310e/3405067/c6b6e5995b51/pone.0041183.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310e/3405067/c6b6e5995b51/pone.0041183.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/310e/3405067/c6b6e5995b51/pone.0041183.g001.jpg

相似文献

1
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.胆石病与非酒精性脂肪性肝病患者的更严重肝损伤相关。
PLoS One. 2012;7(7):e41183. doi: 10.1371/journal.pone.0041183. Epub 2012 Jul 25.
2
Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease.胆囊疾病并不能预测非酒精性脂肪性肝病的肝脏组织学变化。
Gut Liver. 2014 May;8(3):313-7. doi: 10.5009/gnl.2014.8.3.313.
3
Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.脂肪肝疾病:病态肥胖中非酒精性脂肪性肝炎和胆囊疾病的预测因素。
Obes Surg. 2008 Jul;18(7):847-53. doi: 10.1007/s11695-007-9355-0. Epub 2008 May 6.
4
Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.经活检证实的非酒精性脂肪性肝病和非酒精性脂肪性肝炎在成年胆结石患者前瞻性队列中的患病率及危险因素
Liver Int. 2015 Aug;35(8):1983-91. doi: 10.1111/liv.12813. Epub 2015 Mar 5.
5
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.非酒精性脂肪性肝病患者转氨酶水平正常时发生严重肝病的风险:胰岛素抵抗和糖尿病的作用
Hepatology. 2008 Sep;48(3):792-8. doi: 10.1002/hep.22429.
6
Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.经活检证实的非酒精性脂肪性肝病患儿和青少年的糖尿病前期和糖尿病患病率。
J Hepatol. 2019 Oct;71(4):802-810. doi: 10.1016/j.jhep.2019.06.023. Epub 2019 Jul 4.
7
Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)患者的糖尿病前期和糖尿病患病率及代谢特征。
Diabetes Care. 2012 Apr;35(4):873-8. doi: 10.2337/dc11-1849. Epub 2012 Feb 28.
8
Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.FLIP算法和SAF评分在非酒精性脂肪性肝病患者中的临床验证。
J Hepatol. 2020 May;72(5):828-838. doi: 10.1016/j.jhep.2019.12.008. Epub 2019 Dec 17.
9
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.非酒精性脂肪性肝病伴低内脏性肥胖患者的非酒精性脂肪性肝炎和纤维化风险。
J Hepatol. 2011 Jun;54(6):1244-9. doi: 10.1016/j.jhep.2010.09.037. Epub 2010 Nov 11.
10
Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.阿尔巴尼亚超重儿童的非酒精性脂肪性肝病和非酒精性脂肪性肝炎
Minerva Pediatr. 2014 Feb;66(1):23-30.

引用本文的文献

1
Frequency of Gallstones in Patients With Non-alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者胆结石的发生率
Cureus. 2025 Jun 7;17(6):e85508. doi: 10.7759/cureus.85508. eCollection 2025 Jun.
2
Predictors of Gallstones in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).代谢功能障碍相关脂肪性肝病(MAFLD)患者胆结石的预测因素
Cureus. 2025 May 30;17(5):e85073. doi: 10.7759/cureus.85073. eCollection 2025 May.
3
Unraveling the role of GOLM1-OPN-ABCG5 axis in MASH: Editorial on "GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers".

本文引用的文献

1
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.非酒精性脂肪性肝病伴进展性肝纤维化或肝硬化的自然史:一项国际合作研究。
Hepatology. 2011 Oct;54(4):1208-16. doi: 10.1002/hep.24491. Epub 2011 Aug 9.
2
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.系统评价:成人非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学和自然史。
Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30.
3
Diabetes mellitus and the risk of cholecystectomy.
解析高尔基蛋白73-骨桥蛋白-ATP结合盒转运体G5轴在代谢相关脂肪性肝病中的作用:关于“高尔基蛋白73通过ABCG5介导的代谢相关脂肪性肝病肝脏胆固醇流出促进胆固醇胆结石形成”的述评
Clin Mol Hepatol. 2025 Apr;31(2):628-630. doi: 10.3350/cmh.2025.0036. Epub 2025 Jan 16.
4
GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in metabolic dysfunction-associated steatohepatitis livers.高尔基体膜蛋白1(GOLM1)通过ABCG5介导的胆固醇外流促进代谢功能障碍相关脂肪性肝炎肝脏中胆固醇胆结石的形成。
Clin Mol Hepatol. 2025 Apr;31(2):409-425. doi: 10.3350/cmh.2024.0657. Epub 2024 Dec 10.
5
Gallstones increase the risk of nonalcoholic fatty liver: A case-control study.胆结石增加非酒精性脂肪肝风险:一项病例对照研究。
Health Sci Rep. 2024 Nov 5;7(11):e70068. doi: 10.1002/hsr2.70068. eCollection 2024 Nov.
6
Predictive Models for Non-Alcoholic Fatty Liver Disease Diagnosis in Mexican Patients with Gallstone Disease: Sex-Specific Insights.墨西哥胆结石病患者非酒精性脂肪性肝病诊断的预测模型:性别特异性见解
Diagnostics (Basel). 2024 Jul 11;14(14):1487. doi: 10.3390/diagnostics14141487.
7
Causal effects from nonalcoholic fatty liver disease on cholelithiasis: A mendelian randomization study.非酒精性脂肪性肝病对胆石症的因果效应:一项孟德尔随机化研究。
Health Sci Rep. 2024 Mar 18;7(3):e1987. doi: 10.1002/hsr2.1987. eCollection 2024 Mar.
8
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.非酒精性脂肪性肝病或代谢相关脂肪性肝病患者 2 型糖尿病的全球流行病学:系统评价和荟萃分析。
BMC Med. 2024 Mar 6;22(1):101. doi: 10.1186/s12916-024-03315-0.
9
Non-alcoholic Fatty Liver Disease and Gallstones: A Systematic Review.非酒精性脂肪性肝病与胆结石:一项系统综述
Cureus. 2023 Sep 11;15(9):e45027. doi: 10.7759/cureus.45027. eCollection 2023 Sep.
10
Prevalence of nonalcoholic fatty liver disease and the related risk factors among healthy adults: A cross-sectional study in Chongqing, China.非酒精性脂肪性肝病在健康成年人中的流行情况及相关危险因素:一项在中国重庆的横断面研究。
Front Public Health. 2023 Mar 30;11:1127489. doi: 10.3389/fpubh.2023.1127489. eCollection 2023.
糖尿病与胆囊切除术风险。
Dig Liver Dis. 2011 Sep;43(9):742-7. doi: 10.1016/j.dld.2011.04.014. Epub 2011 May 26.
4
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.非酒精性脂肪性肝病伴低内脏性肥胖患者的非酒精性脂肪性肝炎和纤维化风险。
J Hepatol. 2011 Jun;54(6):1244-9. doi: 10.1016/j.jhep.2010.09.037. Epub 2010 Nov 11.
5
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的心血管疾病风险
N Engl J Med. 2010 Sep 30;363(14):1341-50. doi: 10.1056/NEJMra0912063.
6
A position statement on NAFLD/NASH based on the EASL 2009 special conference.基于欧洲肝脏研究学会(EASL)2009年特别会议的非酒精性脂肪性肝病/非酒精性脂肪性肝炎立场声明。
J Hepatol. 2010 Aug;53(2):372-84. doi: 10.1016/j.jhep.2010.04.008. Epub 2010 May 7.
7
Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis.非酒精性脂肪性肝病患者的冠状动脉血流储备受损:与肝纤维化有关。
Atherosclerosis. 2010 Jul;211(1):182-6. doi: 10.1016/j.atherosclerosis.2010.01.049. Epub 2010 Feb 7.
8
Cholelithiasis, cholecystectomy, and liver disease.胆石病、胆囊切除术和肝脏疾病。
Am J Gastroenterol. 2010 Jun;105(6):1364-73. doi: 10.1038/ajg.2009.737. Epub 2010 Jan 12.
9
NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.非酒精性脂肪性肝病作为糖尿病和代谢综合征发生的危险因素:一项为期11年的随访研究。
Am J Gastroenterol. 2009 Apr;104(4):861-7. doi: 10.1038/ajg.2009.67. Epub 2009 Mar 17.
10
Liver test patterns in patients with acute calculous cholecystitis and/or choledocholithiasis.急性结石性胆囊炎和/或胆总管结石患者的肝功能检查模式。
Aliment Pharmacol Ther. 2009 May 1;29(9):1011-8. doi: 10.1111/j.1365-2036.2009.03956.x.